Molecular epidemiology of tuberculosis in the Bata and Malabo districts of Equatorial Guinea

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 12, 2004, Pages 1458-1463

  Tudo G ^a   González Martín, Julián ^a,e   Obama, R ^b   Rodriguez J M ^c   Franco, J R ^c   Espasa, M ^a   Simarro, P P ^c   Escaramis G ^d   Ascaso, C ^d   Garcia A ^a   Jimenez De Anta M T ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b MINISTRY OF HEALTH AND SOCIAL WELFARE   (Equatorial Guinea)

^c Fundacio CIDOB   (Equatorial Guinea)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Africa; Molecular epidemiology; Transmission; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; DISEASE TRANSMISSION; FEMALE; GENE MUTATION; GUINEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHA GENE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SPUTUM SMEAR; TUBERCULOSIS;

ADULT; EPIDEMIOLOGY, MOLECULAR; EQUATORIAL GUINEA; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 19944428444     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. World Health Organization. Stop TB. Annual report 2001. WHO/CDS/STB/2002.17. Geneva, Switzerland: WHO, 2002.
2. World Health Organization. Global Tuberculosis Control, WHO Report 2001. WHO/CDS/TB/2001. Geneva, Switzerland: WHO, 2001.
3. Alland D, Kalkut G, Moss A, et al. Transmission of tuberculosis in New York City. N Engl J Med 1994; 330: 1710-1716.
4. Small P, Hopewell P, Singh S, et al. The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
5. Yang Z H, Mtoni I, Chonde M, et al. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol 1995; 33: 1064-1069.
6. Lockman S, Sheppard J D, Braden C R, et al. Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol 2001; 39: 1042-1047.
7. Bruchfeld J, Aderaye G, Berggren Palme I, et al. Molecular epidemiology and drugs resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002; 40: 1636-1643.
8. Hermans P W, Messadi F, Guebrexabher H, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis 1995; 171: 1504-1513.
9. van Soolingen D, Qian L, de Haas P E, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33: 3234-3238.
10. Godfrey-Faussett P, Sonnenberg P, Shearer S C, et al. Tuberculosis control and molecular epidemiology in South African gold mining community. Lancet 2000; 356: 1066-1071.
11. Wilkinson D, Pillay M, Crump J, Lombard C, Davies G R, Sturm A W. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997; 2: 747-753.
12. Tudo G, González J, Gatell J M, et al. Detection of unsuspected cases of nososcomial transmission of tuberculosis by use of a molecular typing method. Clin Infect Dis 2001; 33: 453-459.
13. Frieden T R, Sherman L F, Maw K L, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. JAMA 1996; 276: 1229-1235.
14. García de Viedma D, Marín M, Hernángomez S, et al. Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favour reinfection. Arc Int Med 2002; 162: 1873-1979.
15. Atlas de la Guinée Équatoriale. Les Atlas de l'Afrique. Les éditions J.A. Paris, France: Lerebours A, 2001.
16. Programa Nacional de Lucha contra la Tuberculosis de Guinea Ecuatorial. Manual de Normas. Malabo, Ecuatorial Guinea: Ministerio de Sanidad y Bienestar Social, 1999.
17. Metchock B G, Nolte F S, Wallace R J, Jr. Mycobacterium. In: Murray P R, Baron E J, Pfaller M A, Tenover F C, Yolken R H, eds. Manual of clinical microbiology, 7th ed. Washington DC: Am Soc Microbiol, 1999: pp 399-437.
18. González J, Tudó G, Gómez J, García A, Navarro M, Jiménez de Anta M T. Use of microscopic morphology in smears prepared from radiometric cultures for presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi. Eur J Clin Microbiol Infect Dis 1998; 17: 493-500.
19. Telenti A, Marchesi F, Balz M, Bally F, Böttger E, Bodmer T. Rapid identification of Mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-178.
20. Sidiqqi S H, Libonati J P, Middlebrook G. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 1981; 13: 908-913.
21. van Embden D J A, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
22. Anti-tuberculosis drug resistance in the world. Report n° 2. Prevalence and Trends. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO/CDS/TB/ 2000.278. Geneva, Switzerland: WHO, 2000.
23. van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacteria infections: main methodologies and achievements. J Intern Med 2001; 249: 1-26.
24. Glynn J R, Bauer J, de Boer A S, et al. Interpreting DNA fingerprinting clusters of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1999; 3: 1055-1060.
25. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tubercle Lung Dis 1992; 73: 73-76.
26. Classen C N, Warren R, Richardson M, et al. Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax 1999; 54: 136-140.
27. Tudó G, González J, Obama R, et al. Study of the anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis 2004; 8: 1-8.
28. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis 2003; 3: 13-21.
29. Solsona J, Caylà JA, Verdú E, et al. Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis 2001; 5: 724-731.